The current business structure of ASI is unsustainable. ASI has initiated a process to implement a new business structure but does not have the financial or physical resources to complete the process. A review of the business structure was undertaken by Morten Rye, as part of CRC project 2008/769, and this review concluded that the ASI business model was flawed but the technical program was sound. Currently ASI receives a levy on improved spat only which means differential pricing of improved and non improved spat. The Rye report stated that differential pricing has been a barrier to uptake for improved stock in many other industries. The outbreak of POMS and the subsequent focus on this as the primary trait for improvement now means that any genetic gains will be to the advantage to the whole of industry. As a result ASI intends to pursue a whole of industry levy. This was endorsed by Rye.